H2BC1 was not expressed in almost all tumor types (Figure S1A), while the other H2B genes were differentially expressed in cholangiocarcinoma, esophageal carcinoma, glioblastoma multiforme (GBM), head and neck squamous cell carcinoma, and cutaneous melanoma (Figures S1B–Q). This evidence concerns the gene H2BC1 and cholangiocarcinoma.